about
Basic science: Pathophysiology: the cardiorenal metabolic syndromeDiabetic kidney disease: a report from an ADA Consensus ConferenceTwo-dimensional zymography differentiates gelatinase isoforms in stimulated microglial cells and in brain tissues of acute brain injuriesThe Role of Overweight and Obesity in the Cardiorenal Syndrome.Micro vs. macrovascular reactivity in insulin resistance: the debate reignited.Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).Fructose and uric acid: is there a role in endothelial function?No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summaryDPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese ratGestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP).Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations.Overnutrition and the Cardiorenal Syndrome: Use of a Rodent Model to Examine Mechanisms.Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study.Obesity and heart failure as a mediator of the cerebrorenal interaction.Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat.Indices of obesity and cardiometabolic riskLow-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female MiceAdaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women.Hypertension Management in Diabetic Kidney DiseaseAwareness of kidney disease and relationship to end-stage renal disease and mortality.Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII.Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db miceThe association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation ProgramHyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket.Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat
P50
Q26823487-A296B2B8-0A19-465B-9110-351E0F5F3308Q27012546-91A08983-4F03-41E9-9BC7-BD1688D989E8Q28546063-4429DFA0-76FD-4A52-A1EC-3C715BF1DA82Q30411964-B034D69E-FD30-44C3-8CFC-63629E7DFCDCQ33559616-9DC5797F-D8F8-4CCE-AAB5-A2CA33A1E951Q33610654-5570E0ED-ED22-4127-90BD-FE252BF06344Q33628045-206D2A5E-9C6C-401E-BE46-CC30635C3A2AQ33746507-05957EE9-6DDD-4100-ACED-A7C8A514D03EQ33854358-B9DD59EF-0672-44D0-A6B8-66A21CFDB1B5Q33920648-DD9A32A5-3928-42E4-B164-256D6690BB6FQ33983415-AD00E3EC-A8C8-406A-8022-0D791EB5E8F4Q34160437-EFC03B26-CE63-4E5D-B462-5579887A4175Q34270500-E4D8AD59-DD15-4F8A-AEBA-AE3D01DC1387Q34351782-3EBBC74A-4201-498A-B819-DE9FA1DD63B8Q34566577-DEA98458-646C-44B4-B9BE-EDD10A1837FBQ34784461-F496D73C-1A65-488E-B4CC-89D43CFCEF6EQ34786884-B111A14D-FCFC-4EB3-8B19-01B7F36B8F08Q35005382-310DA86E-A05B-4D74-AF60-0A9F05C3FAD7Q35005395-EA761E65-FD98-4F85-B7A2-7258F6CD657EQ35044027-2D960A8D-B5CE-4A2F-B5AE-E27BE9BA0EE8Q35057592-4E427812-D0CE-4480-A3EE-7583C5B36659Q35208175-47B132CB-5435-462B-9AC4-68EAA2C78D40Q35395868-E5CF0D28-9563-4DB3-9D8A-E954521CC914Q35575637-787BC464-EB8A-4751-A5A0-B0924B5EF331Q35738015-19031BF4-F9AA-46AF-A35F-8C6D639C0F66Q35789287-0508CE93-3FA9-402F-8FC6-4FDDA548114FQ35819437-2FFDF362-02F0-412C-BD5F-F8E9916F2CCFQ35850828-E68E45FF-0E0E-4BCE-A907-AE66751AE08FQ35953909-DF34CED5-EFAD-4A73-BDC9-1BBE38789789Q36059064-72AF19DA-A19D-4A83-B8EA-770DE7E2986EQ36064143-539C1D4B-D994-4136-8B7A-866C2AB8E55CQ36071729-44DD255D-7050-4FA1-B5F8-F7B83C9D2255Q36277736-260CDB6B-4908-4E60-B7D3-37AB11226C37Q36279580-68CA0398-45C8-4A58-B428-133BFD6D0EDAQ36349415-BCECD0B4-E450-46FB-9324-DED537A78F0EQ36486149-E2F481C3-48F3-41FF-BFDF-177A07B3E64FQ36666443-479D0D58-417D-4BC5-B835-877BF4458568Q36684711-658CFF60-6523-4A09-BAB8-135A0AF93ED8Q36764221-E037B311-B578-4895-9D82-5929F7DDF85FQ36805458-D0582C18-6899-426F-999F-56AB94858EC4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adam T Whaley-Connell
@ast
Adam T Whaley-Connell
@en
Adam T Whaley-Connell
@es
Adam T Whaley-Connell
@nl
type
label
Adam T Whaley-Connell
@ast
Adam T Whaley-Connell
@en
Adam T Whaley-Connell
@es
Adam T Whaley-Connell
@nl
prefLabel
Adam T Whaley-Connell
@ast
Adam T Whaley-Connell
@en
Adam T Whaley-Connell
@es
Adam T Whaley-Connell
@nl
P106
P1153
10142134800
P21
P31
P496
0000-0001-8955-5560